Skip to main content
PMC home page
The Ulster Medical Journal logoLink to The Ulster Medical Journal
. 1987 Oct;56(2):146–148.

Non-menstrual associated toxic shock syndrome.

P G Murphy, W Holmes, T S Wilson, J P Alexander
PMCID: PMC2448239  PMID: 3445394

Full text

PDF
146

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergdoll M. S., Crass B. A., Reiser R. F., Robbins R. N., Davis J. P. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. 1981 May 9;1(8228):1017–1021. doi: 10.1016/s0140-6736(81)92186-3. [DOI] [PubMed] [Google Scholar]
  2. Chesney P. J., Crass B. A., Polyak M. B., Wand P. J., Warner T. F., Vergeront J. M., Davis J. P., Tofte R. W., Chesney R. W., Bergdoll M. S. Toxic shock syndrome: management and long-term sequelae. Ann Intern Med. 1982 Jun;96(6 Pt 2):847–851. doi: 10.7326/0003-4819-96-6-847. [DOI] [PubMed] [Google Scholar]
  3. Christensson B., Hedström S. A. Serological response to toxic shock syndrome toxin in Staphylococcus aureus infected patients and healthy controls. Acta Pathol Microbiol Immunol Scand B. 1985 Apr;93(2):87–90. doi: 10.1111/j.1699-0463.1985.tb02857.x. [DOI] [PubMed] [Google Scholar]
  4. Davis J. P., Chesney P. J., Wand P. J., LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med. 1980 Dec 18;303(25):1429–1435. doi: 10.1056/NEJM198012183032501. [DOI] [PubMed] [Google Scholar]
  5. Garbe P. L., Arko R. J., Reingold A. L., Graves L. M., Hayes P. S., Hightower A. W., Chandler F. W., Broome C. V. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins. JAMA. 1985 May 3;253(17):2538–2542. [PubMed] [Google Scholar]
  6. Reingold A. L., Dan B. B., Shands K. N., Broome C. V. Toxic-shock syndrome not associated with menstruation. A review of 54 cases. Lancet. 1982 Jan 2;1(8262):1–4. doi: 10.1016/s0140-6736(82)92552-1. [DOI] [PubMed] [Google Scholar]
  7. Stolz S. J., Davis J. P., Vergeront J. M., Crass B. A., Chesney P. J., Wand P. J., Bergdoll M. S. Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J Infect Dis. 1985 May;151(5):883–889. doi: 10.1093/infdis/151.5.883. [DOI] [PubMed] [Google Scholar]
  8. Todd J., Fishaut M., Kapral F., Welch T. Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet. 1978 Nov 25;2(8100):1116–1118. doi: 10.1016/s0140-6736(78)92274-2. [DOI] [PubMed] [Google Scholar]
  9. de Saxe M. J., Hawtin P., Wieneke A. A. Toxic shock syndrome in Britain--epidemiology and microbiology. Postgrad Med J. 1985;61 (Suppl 1):5–21. [PubMed] [Google Scholar]

Articles from The Ulster Medical Journal are provided here courtesy of Ulster Medical Society

RESOURCES